| Product Name: | Mometasone Furoate |
| Synonyms: | 9α,21-Dichloro-11β-hydroxy-16α-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate |
| CAS No: | 83919-23-7 |
| Chemical Formula: | C27H30Cl2O6 |
| Grade: | BP/USP |
| Appearance: | Crystalline powder |
| Molar Mass: | 521.44 g/mol |
| Solubility: | Practically insoluble in water; freely soluble in acetone, ethanol, and methanol |
Description
Chemignition is a leading manufacturer and exporter of Mometasone Furoate Active Pharmaceutical Ingredients (API) worldwide. The company adheres to strict Quality Management Systems (QMS) to ensure compliance with Good Manufacturing Practices (cGMPs). This commitment to quality and regulatory standards guarantees that Chemignition produces Mometasone Furoate of the highest quality and efficacy.
Mometasone Furoate serves as a corticosteroid that treats conditions such as allergic rhinitis, asthma, skin conditions, and nasal polyps. It reduces inflammation and suppresses the immune response effectively.
During the manufacturing of Active Pharmaceutical Ingredients (API) and specialty chemicals, Chemignition employs various processes, including dissolution, charcoalization, filtration, leaching, extraction, crystallization, and purification.
Manufacturers commonly use Mometasone Furoate API in pharmaceutical products such as nasal sprays and eye drops.
The U.S. Food and Drug Administration (FDA) first approved Mometasone Furoate in 2006 for treating allergic rhinitis and other related conditions. It comes in various formulations, including nasal sprays and topical creams, and is known for its efficacy and safety profile.
Storage Condition: Pack Mometasone Furoate in a double polybag, keep it in a tightly closed HDPE container, and store it at a temperature between 20°C and 25°C.